Literature DB >> 28560421

A novel damage mechanism: Contribution of the interaction between necroptosis and ROS to high glucose-induced injury and inflammation in H9c2 cardiac cells.

Weijie Liang1, Meiji Chen2, Dongdan Zheng3, Jieyi He1, Mingcai Song1, Liqiu Mo4, Jianqiang Feng5, Jun Lan5.   

Abstract

Recently, a novel mechanism known as 'programmed necrosis' or necroptosis has been shown to be another important mechanism of cell death in the heart. In this study, we investigated the role of necroptosis in high glucose (HG)-induced injury and inflammation, as well as the underlying mechanisms. In particular, we focused on the interaction between necroptosis and reactive oxygen species (ROS) in H9c2 cardiac cells. Our results demonstrated that the exposure of H9c2 cardiac cells to 35 mM glucose (HG) markedly enhanced the expression level of receptor-interacting protein 3 (RIP3), a kinase which promotes necroptosis. Importantly, co-treatment of the cells with 100 µM necrostatin-1 (a specific inhibitor of necroptosis) and HG for 24 h attenuated not only the increased expression level of RIP3, but also the HG-induced injury and inflammation, as evidenced by an increase in cell viability, a decrease in ROS generation, the attenuation of the dissipation of mitochondrial membrane potential and a decrese in the secretion levels of inflammatory cytokines, i.e., interleukin (IL)-1β and tumor necrosis factor (TNF)-α. Furthermore, treatment of the cells with 1 mM N-acetyl‑L‑cysteine (a scavenger of ROS) for 60 min prior to exposure to HG significantly reduced the HG-induced increase in the RIP3 expression level, as well as the injury and inflammatory response described above. Taken together, the findings of this study clearly demonstrate a novel damage mechanism involving the positive interaction between necroptosis and ROS attributing to HG-induced injury and inflammation in H9c2 cardiac cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28560421     DOI: 10.3892/ijmm.2017.3006

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

Review 1.  The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury.

Authors:  Leonid N Maslov; Sergey V Popov; Natalia V Naryzhnaya; Alexandr V Mukhomedzyanov; Boris K Kurbatov; Ivan A Derkachev; Alla A Boshchenko; Igor Khaliulin; N Rajendra Prasad; Nirmal Singh; Alexei Degterev; Evgenia A Tomilova; Ekaterina V Sapozhenkova
Journal:  Apoptosis       Date:  2022-08-20       Impact factor: 5.561

2.  Simultaneous Suppression of Multiple Programmed Cell Death Pathways by miRNA-105 in Cardiac Ischemic Injury.

Authors:  Sunhye Shin; Jung-Won Choi; Hanbyeol Moon; Chang Youn Lee; Jun-Hee Park; Jiyun Lee; Hyang-Hee Seo; Gyoonhee Han; Soyeon Lim; Seahyoung Lee; Sang Woo Kim; Ki-Chul Hwang
Journal:  Mol Ther Nucleic Acids       Date:  2019-01-10       Impact factor: 8.886

3.  Indole-3-acetamides: As Potential Antihyperglycemic and Antioxidant Agents; Synthesis, In Vitro α-Amylase Inhibitory Activity, Structure-Activity Relationship, and In Silico Studies.

Authors:  Khalid Mohammed Khan; Sridevi Chigurupati; Farman Ali; Munissa Younus; Maha Aldubayan; Abdul Wadood; Huma Khan; Muhammad Taha; Shahnaz Perveen
Journal:  ACS Omega       Date:  2021-01-12

4.  GALLIC ACID IMPROVES OXIDATIVE STRESS AND INFLAMMATION THROUGH REGULATING MICRORNAS EXPRESSIONS IN THE BLOOD OF DIABETIC RATS.

Authors:  F Ramezani Ali Akbari; M Badavi; M Dianat; S A Mard; A Ahangarpour
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

Review 5.  Cellular death, reactive oxygen species (ROS) and diabetic complications.

Authors:  Caroline Maria Oliveira Volpe; Pedro Henrique Villar-Delfino; Paula Martins Ferreira Dos Anjos; José Augusto Nogueira-Machado
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

6.  Alterations in necroptosis during ALDH2‑mediated protection against high glucose‑induced H9c2 cardiac cell injury.

Authors:  Tingting Fang; Ruiping Cao; Wenlian Wang; Hongwei Ye; Lin Shen; Zhenghong Li; Junfeng Hu; Qin Gao
Journal:  Mol Med Rep       Date:  2018-07-09       Impact factor: 2.952

Review 7.  Current translational potential and underlying molecular mechanisms of necroptosis.

Authors:  Tamás Molnár; Anett Mázló; Vera Tslaf; Attila Gábor Szöllősi; Gabriella Emri; Gábor Koncz
Journal:  Cell Death Dis       Date:  2019-11-12       Impact factor: 8.469

Review 8.  Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond.

Authors:  Junxia Zhang; Dairu Liu; Mao Zhang; Yan Zhang
Journal:  Br J Pharmacol       Date:  2018-06-25       Impact factor: 8.739

Review 9.  Necroptosis in Intestinal Inflammation and Cancer: New Concepts and Therapeutic Perspectives.

Authors:  Anna Negroni; Eleonora Colantoni; Salvatore Cucchiara; Laura Stronati
Journal:  Biomolecules       Date:  2020-10-10

10.  Upregulation of miRNA-23a-3p rescues high glucose-induced cell apoptosis and proliferation inhibition in cardiomyocytes.

Authors:  Fang Wu; Feng Wang; Qian Yang; Yawen Zhang; Ke Cai; Lian Liu; Shuchun Li; YuanZheng Zheng; Jialing Zhang; Yiting Gui; Youhua Wang; Xu Wang; Yonghao Gui; Qiang Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-11-16       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.